In conclusion, our study demonstrated that estradiol withdrawal elicited a depression- and anxiety-like state in rats and downregulated the BDNF/β-catenin expression in the IL, which could be reversed with ALLO supplementation. The gene discussed is BDNF; the disease is depressive symptom measurement.